title: Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.
abstract: The blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB) play key roles in the influx and efflux transport of endogenous substrates in the brain and cerebrospinal fluid. The organic anion transporter (OAT) 3 and organic cation transporter (OCT) 3, which belong to the solute carrier (SLC) 22A family, are expressed at the BBB and BCSFB, and regulate the excretion of endogenous and exogenous organic anions and cations. Our recent research provides novel molecular and functional evidence that indoxyl sulfate, an anionic uremic toxin, undergoes efflux transport at the BBB via OAT3 and creatinine, a uremic guanidino compound, undergoes efflux transport at the BCSFB via OCT3. Renal impairment is associated with the accumulation of uremic toxins in blood and uremic encephalopathy. It is conceivable that uremic encephalopathy is related to inhibition or dysfunction of efflux transport systems for uremic toxins in the brain. Here, we review the function of OAT3 and OCT3 at the BBB and BCSFB in the context of their roles in the progression of renal failure.
authors: Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630, Sugitani, Toyama 930-0194, Japan. hosoyak@pha.u-toyama.ac.jp
authors: Ken-ichi
authors: K
authors: Hosoya
authors: Masanori
authors: M
authors: Tachikawa
references: J Neurochem. 2006 Feb;96(4):1051-9
references: 16445853
references: Metabolism. 1992 May;41(5):526-32
references: 1588833
references: J Neurosci Res. 2000 May 15;60(4):552-8
references: 10797558
references: J Pharmacol Exp Ther. 1996 Aug;278(2):786-92
references: 8768732
references: Adv Drug Deliv Rev. 2004 Oct 14;56(12):1793-809
references: 15381334
references: J Neurochem. 2008 Oct;107(2):432-42
references: 18752646
references: Fluids Barriers CNS. 2011 Feb 28;8(1):13
references: 21352605
references: Blood Purif. 2008;26(6):526-36
references: 18987466
references: Kidney Int. 2002 May;61(5):1760-8
references: 11967025
references: Pharm Res. 2004 Jan;21(1):61-7
references: 14984259
references: Genome Res. 2001 Jul;11(7):1156-66
references: 11435397
references: Biochim Biophys Acta. 2003 Jan 10;1609(1):1-18
references: 12507753
references: Kidney Int. 2003 May;63(5):1934-43
references: 12675874
references: Br J Pharmacol. 2002 Jul;136(6):829-36
references: 12110607
references: Mol Pharmacol. 2003 Mar;63(3):532-7
references: 12606759
references: Pharm Res. 1996 Jul;13(7):963-77
references: 8842032
references: Mol Cell Biol. 2004 Sep;24(17):7612-21
references: 15314169
references: J Pharmacol Exp Ther. 2003 Jul;306(1):51-8
references: 12684544
references: J Neurochem. 2004 Aug;90(3):526-36
references: 15255930
references: Am J Physiol Renal Physiol. 2007 May;292(5):F1599-605
references: 17244891
references: Semin Dial. 2009 Jul-Aug;22(4):340-5
references: 19708978
references: Clin Lab Med. 1993 Mar;13(1):33-52
references: 8462268
references: J Biol Chem. 2003 Oct 31;278(44):43489-95
references: 12923172
references: J Pharmacol Exp Ther. 1997 Dec;283(3):1018-25
references: 9399971
references: J Histochem Cytochem. 1999 Oct;47(10):1255-64
references: 10490454
references: Clin Pharmacol Ther. 2010 Jan;87(1):39-47
references: 19924123
references: J Cell Physiol. 2005 Sep;204(3):896-900
references: 15795901
references: J Neurochem. 2002 Oct;83(1):57-66
references: 12358729
references: J Pharmacol Exp Ther. 2005 Aug;314(2):932-8
references: 15879000
references: J Biol Chem. 2002 Jul 26;277(30):26934-43
references: 12011098
references: Rinsho Byori. 2010 May;58(5):448-53
references: 20560454
references: Int J Pharm. 2002 Nov 6;248(1-2):15-29
references: 12429456
references: Nagoya J Med Sci. 2010 Feb;72(1-2):1-11
references: 20229698
references: Subcell Biochem. 2007;46:83-98
references: 18652073
references: Clin Neurol Neurosurg. 2004 Dec;107(1):1-16
references: 15567546
references: Metabolism. 1997 Sep;46(9):1024-31
references: 9284891
references: Clin Chim Acta. 1965 Nov;12(5):551-4
references: 5865891
references: J Neurol Neurosurg Psychiatry. 1978 Jul;41(7):581-8
references: 29080
references: Brain Res. 1999 Jan 23;816(2):633-7
references: 9878889
references: Biochim Biophys Acta. 1980 Jul 16;600(1):212-27
references: 7397170
references: Pharm Res. 2010 Oct;27(10):2054-62
references: 20473558
references: Pflugers Arch. 2004 Feb;447(5):666-76
references: 12883891
references: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10346-50
references: 9294213
references: J Clin Endocrinol Metab. 1993 Feb;76(2):318-24
references: 8432774
references: Pharm Res. 2004 Jun;21(6):976-81
references: 15212162
references: Drug Metab Pharmacokinet. 2005 Jun;20(3):200-5
references: 15988122
references: Adv Drug Deliv Rev. 2004 Oct 14;56(12):1875-85
references: 15381338
references: Kidney Int. 2000 Sep;58(3):944-58
references: 10972658
references: J Lab Clin Med. 1994 Jul;124(1):96-104
references: 8035108
references: Kidney Int Suppl. 2001 Feb;78:S77-83
references: 11168988
references: J Am Soc Nephrol. 2002 Jul;13(7):1711-20
references: 12089366
references: Brain Res. 2007 Dec 12;1184:260-9
references: 17988657
references: Physiol Rev. 2000 Jul;80(3):1107-213
references: 10893433
references: J Lab Clin Med. 1975 May;85(5):723-31
references: 1168235
references: Oncogene. 2003 Oct 20;22(47):7468-85
references: 14576852
references: Pharm Res. 2007 Sep;24(9):1745-58
references: 17619998
references: Kidney Int. 2004 Jan;65(1):162-74
references: 14675047
references: Pharm Res. 2005 Apr;22(4):619-27
references: 15846470
references: Annu Rev Physiol. 1998;60:243-66
references: 9558463
references: J Cereb Blood Flow Metab. 2003 Apr;23(4):432-40
references: 12679720